191 related articles for article (PubMed ID: 23176570)
1. Layer-by-layer assembled polypeptide capsules for platinum-based pro-drug delivery.
Zhou D; Xiao H; Meng F; Zhou S; Guo J; Li X; Jing X; Huang Y
Bioconjug Chem; 2012 Dec; 23(12):2335-43. PubMed ID: 23176570
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II).
Xiao H; Qi R; Liu S; Hu X; Duan T; Zheng Y; Huang Y; Jing X
Biomaterials; 2011 Oct; 32(30):7732-9. PubMed ID: 21783244
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable click capsules with engineered drug-loaded multilayers.
Ochs CJ; Such GK; Yan Y; van Koeverden MP; Caruso F
ACS Nano; 2010 Mar; 4(3):1653-63. PubMed ID: 20201548
[TBL] [Abstract][Full Text] [Related]
4. Nanoporous multilayer poly(L-glutamic acid)/chitosan microcapsules for drug delivery.
Yan S; Rao S; Zhu J; Wang Z; Zhang Y; Duan Y; Chen X; Yin J
Int J Pharm; 2012 May; 427(2):443-51. PubMed ID: 22301425
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible polypeptide microcapsules via templating mesoporous silica spheres.
Yu A; Gentle IR; Lu GQ
J Colloid Interface Sci; 2009 May; 333(1):341-5. PubMed ID: 19223040
[TBL] [Abstract][Full Text] [Related]
6. Micellar nanoparticle formation via electrostatic interactions for delivering multinuclear platinum(II) drugs.
Xiao H; Stefanick JF; Jia X; Jing X; Kiziltepe T; Zhang Y; Bilgicer B
Chem Commun (Camb); 2013 May; 49(42):4809-11. PubMed ID: 23595166
[TBL] [Abstract][Full Text] [Related]
7. Low-fouling, biofunctionalized, and biodegradable click capsules.
Ochs CJ; Such GK; Städler B; Caruso F
Biomacromolecules; 2008 Dec; 9(12):3389-96. PubMed ID: 18991459
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs.
Tao Z; Toms B; Goodisman J; Asefa T
ACS Nano; 2010 Feb; 4(2):789-94. PubMed ID: 20131868
[TBL] [Abstract][Full Text] [Related]
9. Functionalized nonporous silica nanoparticles as carriers for Pt(iv) anticancer prodrugs.
Ravera M; Gabano E; Zanellato I; Perin E; Arrais A; Osella D
Dalton Trans; 2016 Nov; 45(43):17233-17240. PubMed ID: 27722707
[TBL] [Abstract][Full Text] [Related]
10. A core cross-linked polymeric micellar platium(IV) prodrug with enhanced anticancer efficiency.
Hou J; Shang J; Jiao C; Jiang P; Xiao H; Luo L; Liu T
Macromol Biosci; 2013 Jul; 13(7):954-65. PubMed ID: 23744619
[TBL] [Abstract][Full Text] [Related]
11. A cross-linked polymeric micellar delivery system for cisplatin(IV) complex.
Song H; Wang R; Xiao H; Cai H; Zhang W; Xie Z; Huang Y; Jing X; Liu T
Eur J Pharm Biopharm; 2013 Jan; 83(1):63-75. PubMed ID: 23046872
[TBL] [Abstract][Full Text] [Related]
12. Copper-free click-chemistry platform to functionalize cisplatin prodrugs.
Pathak RK; McNitt CD; Popik VV; Dhar S
Chemistry; 2014 Jun; 20(23):6861-5. PubMed ID: 24756923
[TBL] [Abstract][Full Text] [Related]
13. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-mediated delivery of multinuclear platinum(IV) prodrugs with enhanced drug uptake and the activity of overcoming drug resistance.
Gao Y; Jiang M; Ma Y; Wu S; Li W; Yang X; Li Y; Jing X; Jiang H
Anticancer Drugs; 2016 Feb; 27(2):77-83. PubMed ID: 26473527
[TBL] [Abstract][Full Text] [Related]
15. What do we know about the reduction of Pt(IV) pro-drugs?
Wexselblatt E; Gibson D
J Inorg Biochem; 2012 Dec; 117():220-9. PubMed ID: 22877926
[TBL] [Abstract][Full Text] [Related]
16. Immuno-chemotherapeutic platinum(IV) prodrugs of cisplatin as multimodal anticancer agents.
Wong DY; Yeo CH; Ang WH
Angew Chem Int Ed Engl; 2014 Jun; 53(26):6752-6. PubMed ID: 24844571
[TBL] [Abstract][Full Text] [Related]
17. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
Ma L; Ma R; Wang Z; Yiu SM; Zhu G
Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
[TBL] [Abstract][Full Text] [Related]
18. [Preparation and biological activity of poly (gamma-glutamic acid) -cisplatin conjugate].
Jin L; Ye HF; Huang J; Jiang L; Hu RZ; Wu ZR
Yao Xue Xue Bao; 2007 Jun; 42(6):611-7. PubMed ID: 17702397
[TBL] [Abstract][Full Text] [Related]
19. Lipophilic Pt(II) complexes with selective efficacy against cisplatin-resistant testicular cancer cells.
Biersack B; Dietrich A; Zoldakova M; Kalinowski B; Paschke R; Schobert R; Mueller T
J Inorg Biochem; 2011 Dec; 105(12):1630-7. PubMed ID: 22071088
[TBL] [Abstract][Full Text] [Related]
20. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
Shi H; Cheng Q; Yuan S; Ding X; Liu Y
Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
